New mammogram machine aims to spot breast cancer earlier

NCT ID NCT07067788

Recruiting now Diagnosis Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new mammogram machine (Siemens MAMMOMAT B.brilliant) to a standard one (Siemens MAMMOMAT Revelation) to see if it provides clearer images of breast calcifications, which can be a sign of cancer. About 100 women with suspicious calcifications will get both scans. The goal is to improve early detection without any new treatments or risks beyond a standard mammogram.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mammogram machine (Siemens MAMMOMAT B.brilliant)
What this could lead to: If successful, this could lead to more accurate breast cancer screening by improving the detection of suspicious calcifications.
What could go wrong: This is a small, early-stage observational study (100 participants) comparing two FDA-approved machines. It does not test a new treatment, and results may not change current screening practices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER SCREENING

Contacts and locations

Locations

Pennsylvania Hospital, Center for Breast Imaging
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.